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Abstract: In the past 15 years, invasion of nerves by cancer cells has escaped from its role 
as a mere bystander in cancer biology and turned into an attractive niche to study the 
heterotypic interaction between cancer cells and neurons. Today, neural invasion (NI) in 
pancreatic cancer (PCa) stands out due to the recent demonstration of its association with 
tumor progression, local recurrence and neuropathic pain. Accordingly, recent research on 
NI in PCa revealed the critical involvement of numerous nerve- or cancer cell-derived 
molecules in several novel in vitro and in vivo models of NI, which, however, still need 
further major improvement.  
Keywords: neural invasion; neurotrophic factors; pancreatic neuropathy; neuroplasticity; 
neurotropism 
 
1. Introduction 
In the “Synthesis” section of their monumental article from 2000 entitled “The hallmarks of cancer”, 
Douglas Hanahan and Robert Weinberg pointed out what may be the most important factor for the 
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correct understanding of the biology of cancer: They complained that current experimental models of 
cancer neglected the crucial dependence of cancer formation “upon changes in the heterotypic 
interactions between incipient tumor cells and their normal  neighbors”  [1]. They added that 
“continuing elucidation of cancer pathogenesis will depend increasingly upon heterotypic organ culture 
systems in vitro and evermore refined mouse models in vivo” [1]. Accordingly, cancer research in the 
past 10 years has not only produced a gigantic amount of scientific information on the intrinsic, genetic 
alterations in cancer cells, but also witnessed a dramatic increase in the number of efforts to understand 
the impact of tumor microenvironment on cancer formation and progression. As a result of these 
efforts, one of the “neighbors” of cancer cells that moved into focus was the nervous system in the 
organ of cancer origin.  Indeed, in several human cancers, nerves have long been observed to be 
frequently invaded by cancer cells [2–5]. However, the human malignancy in which the invasion of 
nerves by cancer cells has attracted by far the highest degree of academic attention and research activity 
has been pancreatic cancer (PCa) [6–8]. Despite increasing apprehension of its pathomechanism, the 
prognosis of PCa has not undergone any significant improvement in the past 50 years: PCa still allows 
a median survival time of a mere six to eight months after diagnosis, and the five-year overall survival 
rate remains around 5% [9–11].  In addition to this utmost dismal prognosis, what motivated 
researchers to increasingly investigate neural invasion (NI) was the high prevalence of NI in PCa, 
reaching up to 100% [6,8], and its strong association with local recurrence after curative tumor 
resection and thus worsened prognosis [12–14]. Initial research on NI in PCa concentrated on its 
detailed anatomic and histopathological characterization. However, over time, research on NI evolved 
to be a fascinating niche to study the complex interaction between cancer cells and nerves at the 
molecular level. At the same time, the resulting emergence of novel in vitro and in vivo models is 
progressing at a hitherto unrivalled pace. Therefore, the present review aims at illustrating the 
historical evolution of research on NI in PCa into the present time and underlining potential future 
directions that might lead to an even better understanding of this peculiar pathologic phenomenon in PCa.  
2. Historical Evolution of Research on Neural Invasion in Pancreatic Cancer 
Anatomists and pathologists seem to have recognized neural cancer cell invasion as early as the 
beginning of 19th  century  [15]. Interestingly, the first attempts to provide a pathomechanistic 
explanation for its occurrence date back to 1905, when Ernst attributed perineural invasion to the 
growth of chondrosarcoma cells within perineural lymphatic vessels [16]. It was again around the 
beginning of the 1930s when the other major theory, i.e., “neurotropism”, emerged as an alternative 
explanation for the generation of NI [17]. In this regard, Jentzer was the first one to note that cancer 
cells made use of nerves as an additional path for invasion. According to Jentzer, this process should 
not be regarded as a mere invasion of nerves by cancer cells because cancer cells actually exploited 
nerves to reach distant destinations during their spread. Thereby, Jentzen underlined that this 
phenomenon should not be termed “neurophilia” but rather “neurotropism” [17]. As later studies failed 
to demonstrate the presence of perineural lymphatic vessels [18], the theory of neurotropism persisted 
into the present time as the most widely accepted explanation for the occurrence of NI in human 
cancers, including PCa.  Cancers 2010, 2                               
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What may be regarded as a lighthouse for increased understanding of NI, particularly in PCa, was 
the pioneering study by Dale Bockman. By examining invaded nerves in the pancreas by electron 
microscopy, he found that cancer cells are by no means limited to the perineurium but delve deeper 
into the endoneurium and establish a close spatial association with endoneural structures including 
axons and Schwann cells [19]. Moreover, one of the major characteristics of NI noted by Bockman was 
“neural damage”: the perineurium was disrupted, the integrity of the whole nerve was distorted, and 
axons had a severely edematous appearance as a result of the invasion by PCa cells [19]. Aside from 
providing the most detailed ultrastructural analysis of NI in PCa, Bockman postulated a key role for the 
transforming growth factor alpha (TGF-α)  in  this  process:  invaded  nerves demonstrated high 
immunoreactivity for the TGF-α, whereas PCa cells expressed high levels of epidermal growth factor 
receptor (EGFR), the natural receptor for TGF-α. Hence, nerves in PCa could represent a major source 
of growth factors for PCa cells, making nerves attractive targets of invasion for PCa cells. This notion 
of nerve-based growth support for PCa cells has dominated into the present time, paving the path for 
numerous studies that recently identified similar growth factors potentially originating from nerves 
during the process of NI, as explained later in this article in detail. 
But is neurotropism sufficient to induce neural invasion? In other words, why have some cancers 
like PCa consistently been identified to bear high degrees of NI as opposed to others? A simple but 
fundamental option to answer these questions was put forward by several authors from Japan based on 
the normal anatomic localization of the human pancreas: The pancreas as a retroperitoneal organ is 
surrounded by several types of neural plexus at its dorsal aspect, including the celiac plexus, dorsal 
hepatic plexus and the plexus around the superior mesenteric artery. Extensive and detailed cadaver 
studies from Japan demonstrated that extrapancreatic neural plexus invasion is encountered in around 
80% of cases and shows a partially repetitive pattern depending on the localization of the pancreatic 
tumor: tumors of the pancreatic head tend to grow towards the celiac plexus and ganglion and along the 
posterior hepatic plexus whereas the pancreatic body and tail tumors spread to the splenic plexus, 
celiac plexus and ganglion [20–22]. It has also been demonstrated that this pattern of spread follows 
the peripancreatic vasculature: Patients with tumors in the ventral pancreas frequently had pancreatic 
head plexus invasion and invasion along mesenteric arterial plexus, whereas patients with dorsal 
tumors had invasion into plexus around common hepatic artery and portal vein [22,23]. These results 
from  cadaver studies have been largely confirmed by very recent imaging studies that employed 
contrast-enhanced  multi-detector row computer tomography (MDCT) [23,24]. Based on these 
observations, Japanese authors have advocated extensive radical surgery involving dissection of the 
peri- and retropancreatic plexus to improve survival [7,20,21]. While some studies proposed better 
survival rates for patients undergoing extended resection [25,26], further studies demonstrated neither a 
reduction in local recurrence  rates nor improved survival as a result of this procedure [27,28]. 
Therefore, the overall prognostic impact of such a radical resection still remains to be determined in 
larger cohorts.  
However, what may be considered a “twist of fate” in research on NI in PCa was the recognition of 
the potential role of NI in the generation of pain in PCa patients. While Bockman also favored further 
investigation of NI due its potential association with pain in PCa [19], it was the cutting-edge study by 
Zhu  et al.  which  for the first time demonstrated a robust correlation between the intrapancreatic Cancers 2010, 2                               
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expression of the nerve growth factor (NGF), the frequency of perineural invasion and the degree of 
pain sensation in PCa patients [29]. This key correlation could be verified by two further studies that 
demonstrated increased abdominal or back pain in patients with increased intrapancreatic expression of 
NGF and its receptor TrkA [30,31]. These studies thereby not only added a novel aspect to the 
nociceptive properties of NGF by attributing it a nociceptive role in a “visceral” organ, but also paved 
the  path for further investigation of nerve-derived factors in the pathomechanism of PCa. The 
consideration and intensified investigation of such neural molecules in the pathomechanism of three 
inter-linked phenomena, i.e., perineural invasion, pain and PCa progression, inaugurated the present 
episode of research on NI in PCa.  
3. Current Concepts on Neural Invasion in Pancreatic Cancer 
The disaffiliation of NI from the role of a mere bystander in PCa and the increasing recognition of 
its importance fostered the motivation to achieve an even more detailed characterization of its natural 
and histopathological properties. As a result, two studies in current medical literature emerge as the 
most comprehensive ones, describing multiple aspects of NI in PCa: 
First, in the study by Kayahara et al., the investigators examined consecutive sections of surgically 
resected PCa specimens to investigate the mechanism and mode of spread in NI. They could thereby 
identify  five  main patterns of cancer cell growth along nerves: (1) direct invasion of the nerves;  
(2) continuous tumor cells growth in the perineural space; (3) branching of the growing tumor mass 
along neural branches; (4) formation of a foremost growth cone of tumor cells; and (5) direct invasion 
of contiguous lymph nodes. This study by Kayarara et al. bears the importance of being the first study 
which tried to identify an anatomical mechanism for the manifestation of NI and particularly 
extrapancreatic neural plexus invasion. Therefore, it demonstrated that NI involves continuous growth 
of PCa cells along nerves towards the extrapancreatic neural plexus. However, it should be noted the 
prevalence of continuous cancer cell growth along nerves should not necessarily be considered as the 
only mechanism for spread of NI in PCa. Interestingly, it could be demonstrated that in nearly more 
than 50% of all examined PCa specimens, NI can be encountered in normal pancreatic areas that are 
distant from the main tumor, a phenomenon which was termed “nex” [32,33]. Moreover, the presence 
of nex strongly correlated with the presence of extrapancreatic nerve plexus invasion, and thus should 
be regarded as a poor prognostic sign [32,33].  
In the second study, our group aimed at performing the currently largest-scale systematic analysis of 
NI in PCa by including a total of 546 patients with different pancreatic tumors, i.e.,  ductal 
adenocarcinoma, neuroendocrine tumors, benign pancreatic tumors, etc. [34]. One of the first findings 
of that study was the demonstration of its multiple manifestations: as initially described by Bockman, 
cancer cells were seen to be not confined to the perineural layer, but to penetrate into the endoneurium 
and towards nerve fibers. In order to attain a proper quantification of its different manifestations, we 
introduced a novel standardized scoring system that differentiates between perineural (PNI) and 
endoneural invasion (ENI). The mentioned study demonstrated that ductal adenocarcinoma of the 
pancreas bears a far higher degree of NI in comparison to all other pancreatic tumors (Figure 1). 
Furthermore, this study could also strengthen the previously suggested involvement of NI in pain 
sensation: patients whose nerves exhibited ENI had more frequent and intense pain than patients who Cancers 2010, 2                               
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merely had PNI. Moreover, PCa was seen to be not only characterized by NI, but also by several other 
neuroplastic alterations including neural hypertrophy, increased neural density and neural inflammatory 
cell infiltration (“pancreatic neuritis”) (Figure 1) [34]. Strikingly, the same study also identified a 
prominent association between the severity of NI in PCa and the extent of intrapancreatic neuroplastic 
alterations: Enlarged and sprouting nerves were at the same time the ones that exhibited NI. In a 
subsequent study, we could also demonstrate that these plastic alterations additionally included a 
remarkable switch in the pancreatic innervation quality: nerves invaded by cancer cells harbored a 
much lower amount of sympathetic and cholinergic nerve fibers (Figure 2) [35]. There is increasing 
evidence that these neuroplastic alterations in PCa are due to the neurotrophic attributes of the 
microenvironment in PCa, as demonstrated by another recent study by our group. In this study, we 
observed that tissue extracts of PCa, PCa cell supernatants and supernatants of human pancreatic 
stellate cells as main generators of desmoplasia can all induce axonal sprouting, increased neurite 
density and perikaryonal hypertrophy of neurons under in vitro conditions [36].  
The strong association between pancreatic neuroplastic alterations and pain sensation by PCa 
patients points to the presence of a “neuropathic” pain mechanism in PCa, since the currently accepted 
definition for neuropathic pain is “pain arising as a direct consequence of a lesion or disease affecting 
the somatosensory system” [37]. Obviously, the neural damage in conjunction with NI plays a major 
role in this visceral neuropathy. Hence, the introduction of neuropathic analgesic regimens into the 
treatment of patients with advanced PCa may be of potential benefit. 
Figure 1. Neural invasion (NI) in pancreatic cancer (PCa) and pancreatic neuroplasticity 
are interlinked phenomena. NI is encountered in nearly all cases of ductal adenocarcinoma 
of the pancreas either within or adjacent to the main tumor mass (top panel). 
Histopathologic examination of the pancreatic tumor together with peripancreatic areas 
demonstrates a drastically increased number and size of intrapancreatic nerves (middle 
panel, 25× magnified, nerves were immunohistochemically/brown-labeled with the pan-
neuronal marker protein gene product 9.5/PGP9.5). A closer look at these hypertrophic 
nerves reveals a high frequency of NI, even in the endoneural space (lower panel; 200x 
magnification, cancer cells correspond to the hematoxylin-counterstained areas within the  
brown-PGP9.5-immunostained nerve).  Cancers 2010, 2                               
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Figure  2.  Neural invasion (NI) in pancreatic cancer (PCa) is associated with a 
“remodeling” of intrapancreatic nerves. Analysis of nerve fiber qualities in the 
hypertrophic, sprouting and invaded nerves in PCa revealed that the proportion of 
sympathetic and cholinergic nerve fibers in these nerves is much smaller than in normal 
pancreatic nerves. Therefore, the quality of the remaining fibers in these nerves remains to 
be identified. 
 
4. Molecular Mediators of Neural Invasion in Pancreatic Cancer: the Emergence of Novel  
in Vitro Models 
The past 10 years of NI research has also been marked by a constant rise in the number of studies 
that aimed at identifying potential mediators of the attraction between PCa cells and nerves. It is quite 
remarkable that these efforts have recently given birth to numerous novel advanced in vitro models of Cancers 2010, 2                               
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NI in PCa. In the first of these models, Dai et al. co-cultivated the human PCa cell line MiaPaCa-2 
together with mouse dorsal root ganglia (DRG) and observed enhanced PCa cell growth than among 
non-co-cultured control PCa cells [38]. This enhanced growth was also evidenced by the   
over-expression of prosurvival genes like MALT1 and TRAF [38]. Importantly, the authors also noted 
reciprocity between neurite outgrowth and PCa cell proliferation in this assay: The better the cancer 
cells grew, the more prominent was the neurite outgrowth from DRG.  
In a recent study, our group presented another in vitro approach that allows a precise spatiotemporal 
monitoring of NI by PCa cells. There, we co-cultivated different PCa cell lines together with rat DRG 
or myenteric plexus (MP) cells in a three-dimensional (3D) extracellular matrix (ECM)-based 
migration assay. As opposed to all currently available in vitro models in the literature, the migration 
assay we presented requires an initial clear-cut physical separation of PCa cells and neurons, as it is the 
case under in vivo conditions. Owing to such an initial physical separation, the model allows the exact 
demonstration of the initial reaction of each cell type to the co-culture conditions. Furthermore, the 
model includes a pre-defined migration path for PCa cells, i.e., defined ECM-bridges, which ensures 
the formation of a signal molecule gradient for any chemotactic factor. This way, we could demonstrate 
that PCa cells facing the neurons react to the presence of neurons with a typical morphological 
alteration,  i.e.,  flattening, grouping, colony formation and spike-like cellular polarization directed 
towards neurites. Moreover, PCa cells progressively come into contact with neurites along which they 
migrate in a targeted fashion. As suggested by Dai et al., the co-presence of PCa cells and neurons was 
seen to be marked by a mutual growth support and tropism. Furthermore, one of the major strengths of 
the presented model was the inclusion of MP cells of the enteric nervous system (ENS). It should be 
considered that the extrinsic component of the pancreatic innervation,  
i.e., nerve fibers running within the vagal and splanchnic nerves, originate from DRGs or vagal nuclei, 
respectively, whereas the intrinsic component is represented by pancreatic neurons derived from enteric 
neurons [39,40]. Therefore, the usage of MP and DRG cells provides a much more realistic model for 
studying the whole pancreatic innervation than using the DRG alone [6]. In the same study, we also 
monitored the quantitative alterations in the expression of neurotrophins, their receptors and the 
members of the glial-cell-derived neurotrophic factor (GDNF) family. Interestingly, while the majority 
of these factors did not demonstrate major expression changes, the nerve growth factor (NGF) 
increased steadily throughout the migration process of 120 hours [6]. Hence, the presented 3D model 
on the one hand confirmed the previously suggested crucial role of NGF in the NI [29], but also stood 
out as a promising model to identify further key mediators of NI in future studies. 
As evidenced by other studies, NGF seems to be only one of several other molecular actors in the 
generation of NI (Figure 3). The potential role of chemokines was quickly recognized and investigated 
in a recent study by Marchesi et al., who aimed at unveiling the involvement of the neuronal 
chemokine fractalkine (CX3CL1) in NI [41]. They could show that the neural immunoreactivity for the 
receptor of fractalkine, i.e., CX3CR1, was significantly higher in perineural invasive lesions of PCa, 
and it was the CX3CR1-transfected, in vivo implanted PCa cells that exhibited a remarkable infiltration 
of peripheral nerves (Figure 3). Overall, they could prove that the CX3CR1 receptor may be involved 
in PCa neurotropism and serve as an independent risk factor for early local recurrence. Therefore, the 
CX3CR1-CX3CL1 axis was pointed out as a valuable therapeutic target to prevent tumor recurrence Cancers 2010, 2                               
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and progression in PCa [41]. Further studies shedding light on the role of chemokines in NI are 
underway. 
In harmony with these studies, nerve-derived molecules have recently been the focus of further 
studies on NI (Figure 3). From these, Hibi et al. could show that the expression of synuclein gamma, 
which is involved in several neurodegenerative diseases, is a predictor of overall survival. Furthermore, 
in mouse perineural invasion and orthotopic transplantation models, stable synuclein-γ suppression by 
short hairpin RNA significantly reduced the incidence of perineural invasion and liver and lymph node 
metastasis [42]. A similarly impaired survival and increased rates of perineural invasion were also 
demonstrated for the intrapancreatic over-expression of neurite growth-promoting factor pleiotrophin 
[43]. Furthermore, Gil et al. demonstrated in a recent in vitro model involving DRG and PCa cell lines 
a major role for GDNF in the neurite-targeted migration of PCa cells: DRG derived from mice 
deficient in GDNF failed to attract PCa cells, and systemic blockade of the receptor tyrosine kinase 
RET, which is a downstream target of GNDF, could prevent NI toward the spinal cord and paralysis in 
mice [44]. A similar role for another GDNF family member, namely artemin, could be shown by our 
group, as artemin significantly increased the invasiveness of PCa cells and was over-expressed in PCa 
tissue [12]. 
Figure 3. The interplay between neuronal and cancer-cell-derived factors in the generation 
of neural invasion (NI) in pancreatic cancer (PCa). Research from the past 10 years has 
revealed a crucial involvement of several neurotrophic factors (e.g., NGF, GDNF, artemin), 
chemokines (e.g.,  fractalkine), pro-survival genes (MALT1, TRAF) and cell-surface 
receptors (CD74, MAG) in the neuro-cancer interactions and NI in PCa. Please see the 
manuscript for the respective references. 
 
As part of recent efforts to obtain a more comprehensive analysis and overview of the potential 
molecular actors in NI, Abiatari et al. recently reported on the generation of a transcriptome signature 
of NI in PCa by means of another in vitro/ ex vivo model. In their study, they co-cultivated human PCa 
cell lines with explanted rat vagus nerves and analyzed the consensus set of genes differentially 
regulated in all highly versus less nerve-invasive PCa cells [45]. Thereby, they could identify the Cancers 2010, 2                               
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differential expression of kinesin family member 14 (KIF14) and Rho-GDP dissociation inhibitor beta 
(ARHGDIbeta) in perineural invasion, which was confirmed on the RNA and protein levels in human 
PCa  specimens.  Moreover, small interfering RNA-mediated downregulation  of KIF14 and 
ARHGDIbeta resulted in diminished perineural invasion [45]. Based upon this transciptome analysis, 
the authors put forward two other molecules, i.e., the microtubule-associated protein MAPRE2 and the 
nuclear protein YPEL2, as molecules with derangements in their expression during NI in PCa [46,47]. 
In another recent outstanding study, Swanson et al. provided a novel insight to the neuro-cancer 
interactions by identifying the receptor for the transmembrane mucin MUC1 in the pancreas [48]. 
MUC1 is overexpressed and differentially glycosylated in several adenocarcinomas including PCa, and 
this aberrant glycosylation is associated with monosialyl and disialyl T-structure [48]. They could show 
that MUC1 expressed by cancer cells can bind to myelin-associated glycoprotein (MAG) expressed on 
Schwann cells of peripheral nerves, as evidenced by in vitro adhesion assays and immunohistochemical 
analysis of NI lesions in PCa specimens [49]. Hence, they could not only identify a novel heterotypic 
interaction, but provided a direct correlate of the close spatial relationship of nerves and cancer cells in 
PCa, as initially observed by Bockman [19].  
 
 
5. In Vivo Models of Neural Invasion in Pancreatic Cancer: The Long Way to Perfection 
The recent but steady increase in the number of in vitro models of NI in PCa seems to be in part 
paralleled by a similar tendency to generate realistic in vivo models. The first one of these in vivo 
approaches seems to have been performed by Eibl et al., who attempted to simulate the high rates of 
local recurrence and perineural invasion after curative pancreatic tumor resection [50]. There, the 
investigators first performed an orthotopic implantation of the PCa cell lines MiaPaCa-2 
(undifferentiated) and Capan-2 (well-differentiated) in nude mice pancreas and attempted a complete 
surgical resection of the tumor at four, six, and eight weeks post implantation. Nude mice who had 
received MiaPaCa-2 cells initially developed local tumor recurrence with extensive retroperitoneal 
nerve invasion and distant  organ  metastasis  six  weeks  post implantation [50].  Hence, the authors 
achieved a realistic simulation of the local recurrence and NI associated with PCa in a murine model, 
which may well allow the study of the course of NI following tumor resection [50]. However, the main 
limitation of the presented model is that invasion of extrapancreatic neural plexus is a rather late event 
in PCa, and probably even early stage PCa localized to the pancreas already bears a prominent degree 
of intrapancreatic NI [7,19,32–34]. Therefore, the initial, and probably deciding, events leading to NI 
are unlikely to be studied by means of this model. 
A frequently cited model of NI in PCa was created by Koide et al.: In their study, the investigators 
subcutaneously (s.c.) implanted seven different PCa cell lines with or without human peripheral nerves 
in non-obese diabetes/severe combined immunodeficient mice and analyzed the frequency of NI by 
these different cell lines [51]. Additionally, they performed an oligonucleotide microarray to obtain the 
expression profiles of high and low perineurally invasive cell lines. Four out of the seven selected cell 
lines presented invasion of the implanted human nerves; however, this invasion was very frequently 
accompanied by perineural inflammation. Therefore, the investigators refrained from further Cancers 2010, 2                               
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investigating the invasion of implanted peripheral  nerves but limited themselves to the perineural 
invasion around mouse s.c. nerves. It was only two well-differentiated cell lines (Capan-1 and Capan-2) 
that invaded mouse s.c. nerves. Furthermore, they identified over-expression of CD74 in the 
perineurally invasive cells, which was confirmed by analysis of PCa tissue specimens. Altogether, the 
authors presented a possibility of investigating the process of NI in another xenograft model which is 
still limited by the preferential invasion by well-differentiated cell lines and the major lack of 
concomitant neuroplastic alterations that are idiosyncratic for human PCa [34]. Moreover, the model 
does not involve the natural nerves of the actual end-organ, i.e., pancreatic nerves, which are mainly 
autonomic nerves as opposed to the somatic subcutaneous nerves. 
There is currently a single in vivo  model of NI in PCa,  which was designed with a primarily 
therapeutic intention. In this study, Gil et al. injected PCa cell lines into the perineurium of the sciatic 
nerve of athymic mice and monitored limb function for nine days after injection [52]. Strikingly, they 
could show that a single injection of an attenuated, replication-competent, oncolytic herpes simplex 
virus  seven  days after intraneural PCa cell injection can effectively treat invaded  nerves  without 
compromising physiological nerve function [52]. In a subsequent study, the same authors presented the 
utility of this model for intraoperative diagnosis of NI [53]. Specifically, after intrasciatic implantation 
of PCa cell lines, they injected the same attenuated virus, this time with enhanced green fluorescent 
protein expression (eGFP), into the sciatic nerve. By employing intraoperative fluorescent stereoscopic 
imaging to detect the eGFP, they could identify the nerves invaded by PCa cells [53]. Therefore, the 
authors advocated oncolytic viruses for enhanced diagnosis of PCa due to facilitated detection of 
invaded nerves that would be subject to resection, and as a novel therapy regimen. Undoubtedly, the 
efforts of Gil et al. occupy a special place due to the concomitant dedication of the group to generate 
novel therapeutic approaches to NI and to elucidate its exact pathomechanism. However, the actual 
sensitivity of their method to fully detect and to eradicate NI remains to be determined. 
6. Future Directions in Research on Neural Invasion in Pancreatic Cancer: “The Best Is Yet  
to Come” 
The breathtaking evolution of research on NI and the rapidly growing scientific interest in NI are 
heralding an era of numerous further discoveries in the neuro-cancer interactions in PCa. The above 
outlined specifics of NI research at the same time point out the multiple aspects of NI that are waiting 
to be unveiled. Certainly, the achievement of future discoveries in this field is going to depend on the 
careful and critical appraisal of current findings and the generation of even more interesting questions 
pertinent to the pathogenesis of NI.  
To name some of potentially interesting aspects, we are convinced that the main hypothesis for the 
generation of NI, i.e., the neurotropism of PCa cells, has to be carefully reviewed. As evidenced by 
previous studies, holding cancer cells responsible for every aspect of NI and omitting the contribution 
of neurons to this process may turn out to be totally incorrect. The role of NGF, GDNF, artemin, 
fractalkine and CX3CR1, MAG and several other nerve-derived molecules should serve as a 
motivation for comprehensive screening of alterations in the expression of neuronal molecules during NI.  
Second, despite the impressive and rapid development of novel astute in vitro models, all of the NI 
models need to be verified for their specificity for PCa and NI in general. This can be achieved via Cancers 2010, 2                               
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inclusion of, e.g., cancer cells that normally exhibit little or no NI, or via co-culturing of cancer cells 
with non-neuronal cells. What is more, although several in vitro models make use of extracellular 
matrix (ECM) gel-based assays, the intrinsic ability of ECM components like fibronectin, laminin and 
collagen subtypes to guide cellular migration should not be underestimated. As shown in a recent 
study, these molecules can be preferentially expressed by the perineurium and guide cancer cells in 
their migration along nerves [54]. Therefore, for studies primarily investigating chemotactic agents in 
NI, the exclusion of large amounts of ECM proteins may help with the elimination of confounding factors.  
Finally, there still seems to be a need for improved in vivo models of NI in PCa since current models 
fail to represent the NI in a realistic manner due to the above mentioned reasons. Considering these, an 
ideal in vivo model of NI in PCa could be characterized by (1) origination of the tumor from the 
pancreas; (2) the presence of a ductal adenocarcinoma in the pancreas; (3) the presence of NI even at 
early stages of PCa;  (4) the specific extension of NI towards the extrapancreatic neural plexus;  
(5) no need for iatrogenic injection of tumor cells through the epineurium;  (6) accompanying 
neuropathic and desmoplastic alterations and (7) concurrent pain. An intriguing question in this regard 
is whether these features can be realized in murine models of NI due to the normal anatomic 
localization of the pancreas in these animals when compared to the retroperitoneal localization of 
human pancreas. The human pancreas is surrounded by numerous neural plexus at its rear border [20–22]; 
however, similar studies on retropancreatic neural plexus in mice or rats are not present. Therefore, 
careful investigation of the peripancreatic plexus anatomy may help better predict the usefulness of 
animal models to simulate human NI in PCa. 
7. Conclusions 
Although more than 100 years old, research on the invasion of nerves by pancreatic cancer cells has 
only gained speed in the past 10 years, owing to the recognition of the close relationship between NI, 
pain, survival and tumor recurrence. Accordingly, the current expectations associated with research on 
NI comprise discovery of novel tools to limit local tumor spread, recurrence and prevention  or 
treatment of neuropathic pain due to NI. Undoubtedly, the fulfillment of these expectations necessitates 
proper and in-depth understanding of the multiple interactions between cancer cells and nerves. 
Invasion of nerves by PCa cells is traditionally attributed to a neurotropism of PCa cells, whereas 
recent findings underscore the reciprocity of the tropism between cancer cells and neurons. Despite the 
discovery of numerous molecular mediators of this tropism, most studies include genome-wide 
analyses carried out in the cancer cells only, possibly due to the technical difficulties associated with 
the performance of similar studies in neuronal cells. However, as demonstrated by recent advanced in 
in vitro and in vivo models, the functional modulation of such neuronal agents bears high diagnostic 
and therapeutic potential. Also in this fascinating field of research, future developments and 
discoveries heavily depend on the critical appraisal and refinement of the present experimental models, 
as suggested by Hanahan and Weinberg at the end of the last millennium [1]. To conclude with their 
own words, it remains to be hoped that, for the generation of effective therapeutic regimens in PCa, the 
future research on NI in PCa is also going to assume a direction “where the complexities of the disease, 
described in the laboratory and clinic, will become understandable in terms of a small number of 
underlying principles” [1]. Cancers 2010, 2                               
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